PBC Biomed are ready for action at the Orthopaedic Trauma Association meeting in Montreal! Stop by booth #431 to meet our team and learn more about our new #innovations, powered by our Accelerating Innovation Model ‘AIM’. #acceleratingmedicalinnovation #biomaterials #newinnovations

In September, PBC Biomed and our client Mochida Pharmaceutical., Ltd. hit a significant milestone in our co-development journey. Together, we launched ReFeel® at the American Society for Surgery of the Hand (ASSH) meeting event in Minneapolis, where we demonstrated the technology publicly for the first time with the help of our surgeon advisors. Thank you to Dr Rashard Dacus, Dr Glenn Gaston and Dr William Jake Weller for stopping by our booth to demonstrate application of ReFeel® using our new training models, as well as their guidance throughout the development process of this exciting new technology. We are thrilled to release this new product in the US for treatment of patients with peripherical nerve discontinuities and management of nerve injuries. #ReFeel® #nerverepairsolution #acceleraratingmedicalinnovation #ASSH24

PBC Biomed are delighted to announce the launch of our client Mochida Pharmaceutical Co., Ltd. innovative new nerve repair product – ReFeel® Nerve Repair Solution. ReFeel® is #biocompatible in nature and uses a proprietary alginate and PGA formula to create a bridge for #nerve #regeneration. The freeze-dried alginate sheet suppresses the migration and proliferation of cells that make up granulation tissue; providing a protected environment which facilitates the natural healing process of the nerve. The PBC Biomed Design & Development, Clinical, Regulatory and Commercial teams have been working alongside Mochida Pharmaceutical Co., Ltd. for the last four years; preparing this technology for commercial release. ReFeel® will officially be launched at the American Society for Surgery of the Hand (ASSH) conference in Minneapolis this week. Visit booth #210 for more information on this exciting new technology! Caution: Prescription use only. Federal law (USA) restricts this device to sale by or on the order of a physician. #acceleraratingmedicalinnovation #ASSH24

We are delighted to introduce our new company video, created by Christian Gyalus at Éalú Media. This video provides a fantastic insight into our mission, to enhance patient wellbeing by accelerating medical innovation; as well as the work that we do to achieve this mission. Huge thank you to Christian for making our vision a reality, and to the team for their support and contribution. We are thrilled with the end result! #pbcbiomed #acceleraratingmedicalinnovation #mission

That’s a wrap on this year’s Orthopedic Design & Technology Forum! Our team on the ground – Brittney Martinez and David Sharp, enjoyed a fantastic day of discussion, learning and opportunities to grow the PBC Biomed network in the US. This was our first time exhibiting at the event since we opened our Memphis office at the start of 2023 – it certainly will not be our last! If you missed Brittney and David at the event, please feel free to get in touch with us via email. Contact [email protected] for more information on our company, our people and what we do!

Innovative new medical implants could be on the way following a deal between PBC BioMed and I-Form, the Science Foundation Ireland-backed research centre. The €300,000 four-year agreement is for a project to investigate the feasibility of manufacturing magnesium-based medical implants using state-of-the art metal 3D printing and coating processes. The aim is to demonstrate improved implant performance while developing a novel, cost- effective, advanced manufacturing process. Article by Charlie Taylor on Irish Times. Image: Prof Nicholas Dunne, who is leading the I-Form team along with Dr Tanya Levingstone at DCU